Skip to content
10-K

Annual Report

Evome Medical Technologies, Inc.

0001062993-24-008449

← back to feed
Filed
Apr 16, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Apr 9, 2024 57.83M sh
Shares Diluted FY 2023 · Dec 31, 2023 73.47M sh
Shares Diluted FY 2023 · Dec 31, 2022 54.84M sh
Capex FY 2023 · Dec 31, 2023 203.27K
Capex FY 2023 · Dec 31, 2022 639.47K
Operating Cash Flow FY 2023 · Dec 31, 2023 −918.91K
Operating Cash Flow restated FY 2023 · Dec 31, 2022 −827.56K
Long Term Debt FY 2023 · Dec 31, 2023 257.17K
Long Term Debt FY 2023 · Dec 31, 2022 574.52K
Short Term Debt FY 2023 · Dec 31, 2023 10.41M
Short Term Debt FY 2023 · Dec 31, 2022 195.49K
Cash And Equivalents FY 2023 · Dec 31, 2023 918.68K
Cash And Equivalents FY 2023 · Dec 31, 2022 1.93M
Stockholders Equity FY 2023 · Dec 31, 2023 4M
Stockholders Equity FY 2023 · Dec 31, 2022 15.33M
Stockholders Equity FY 2023 · Feb 28, 2022 13.15M
Current Liabilities FY 2023 · Dec 31, 2023 37.57M
Current Liabilities FY 2023 · Dec 31, 2022 30.16M
Total Liabilities FY 2023 · Dec 31, 2023 44.25M
Total Liabilities FY 2023 · Dec 31, 2022 36.72M
Current Assets FY 2023 · Dec 31, 2023 21M
Current Assets FY 2023 · Dec 31, 2022 16.6M
Total Assets FY 2023 · Dec 31, 2023 48.26M
Total Assets FY 2023 · Dec 31, 2022 52.05M
Eps Diluted FY 2023 · Dec 31, 2023 −0.21
Eps Diluted FY 2023 · Dec 31, 2022 −0.29
Eps Basic FY 2023 · Dec 31, 2023 −0.21
Eps Basic FY 2023 · Dec 31, 2022 −0.29
Sga Expense FY 2023 · Dec 31, 2023 23.55M
Sga Expense FY 2023 · Dec 31, 2022 11.4M
Net Income FY 2023 · Dec 31, 2023 −15.6M
Net Income FY 2023 · Dec 31, 2022 −15.9M
Operating Income FY 2023 · Dec 31, 2023 −5.52M
Operating Income FY 2023 · Dec 31, 2022 −2.65M
Gross Profit FY 2023 · Dec 31, 2023 22.53M
Gross Profit FY 2023 · Dec 31, 2022 10.56M
Cost Of Revenue FY 2023 · Dec 31, 2023 40.09M
Cost Of Revenue FY 2023 · Dec 31, 2022 23.03M